Literature DB >> 2223387

Transforming collaborations between ras and nuclear oncogenes.

H E Ruley1.   

Abstract

Nuclear proteins encoded by both cellular oncogenes and DNA tumor viruses enable activated ras oncogenes to transform a variety of cell types to a tumorigenic state. The interactions are complementary, suggesting that collaborating oncogenes release cells from controls that preclude transformation by ras alone. The nuclear oncoproteins bind both protein and nucleic acid targets and affect processes important in transcription and cell cycle control. Transforming collaborations between oncogenes provide a genetic context to study biochemical interactions involved in normal growth control and to identify mechanisms important in multistep carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223387

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  25 in total

1.  Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.

Authors:  P Rieske; J Bartkowiak; A Szadowska; M Debiec-Rychter
Journal:  Mol Pathol       Date:  1999-04

2.  Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.

Authors:  S Gupta; R Plattner; C J Der; E J Stanbridge
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  BRCA1 partially reverses the transforming activity of the ras oncogene.

Authors:  A Kumar; C Knott; K Kuus-Reichel; M S Saedi
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins.

Authors:  A V Samuelson; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 5.  Mitogenic pathways regulated by G protein oncogenes.

Authors:  S K Gupta; C Gallego; G L Johnson
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

6.  p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene.

Authors:  Sophie Vasseur; Albrecht Hoffmeister; Stephane Garcia; Claude Bagnis; Jean-Charles Dagorn; Juan Lucio Iovanna
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

Review 7.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

Review 8.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

9.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Authors:  Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.